Dr. Melchert is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
403 S Kings Ave
Ste 100
Brandon, FL 33511Phone+1 813-982-3460Fax+1 813-982-3461
Education & Training
- University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2003 - 2006
- Vanderbilt University Medical CenterResidency, Internal Medicine, 2000 - 2003
- University of South Florida College of MedicineClass of 2000
Certifications & Licensure
- FL State Medical License 2003 - 2026
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011-2014
Publications & Presentations
PubMed
- 22 citationsA multicenter, phase II study of maintenance azacitidine in older patients with acute myeloid leukemia in complete remission after induction chemotherapy.Patrick T. Griffin, Rami S. Komrokji, Carlos M. de Castro, David A. Rizzieri, Magda Melchert
American Journal of Hematology. 2015-09-01 - 170 citationsThe thalidomide saga.Magda Melchert, Alan F. List
The International Journal of Biochemistry & Cell Biology. 2007-07-01 - 27 citationsThe role of lenalidomide in the treatment of patients with chromosome 5q deletion and other myelodysplastic syndromes.Magda Melchert, Vishakha Kale, Alan F. List
Current Opinion in Hematology. 2007-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: